Stock A052670 CHEILBIO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Cheilbio Co., Ltd. Share Price

Equities

A052670

KR7052670007

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 03:30:00 20/07/2023 am IST 		5-day change 1st Jan Change
2,080 KRW -9.96% Intraday chart for Cheilbio Co., Ltd. -.--% -.--%
2023 Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
2023 Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI

Financials

Sales 2022 15.35B 11.11M 928M Sales 2023 12.11B 8.77M 732M Capitalization 56.18B 40.68M 3.4B
Net income 2022 -1.71B -1.24M -103M Net income 2023 -1.45B -1.05M -87.41M EV / Sales 2022 0.75 x
Net cash position 2022 22.09B 15.99M 1.34B Net cash position 2023 19.83B 14.35M 1.2B EV / Sales 2023 3 x
P/E ratio 2022
-20 x
P/E ratio 2023
-38.5 x
Employees 76
Yield 2022 *
-
Yield 2023
-
Free-Float 67.43%
More Fundamentals * Assessed data

Chart Cheilbio Co., Ltd.

Dynamic Chart

Latest news about Cheilbio Co., Ltd.

Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022. CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022. CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on April 13, 2022. CI
Cheilbio Co., Ltd.'s Equity Buyback announced on April 13, 2022, has expired with 1,246,452 shares, representing 4.41% for KRW 2,999.36 million. CI
Cheilbio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Cheilbio Co., Ltd. announces an Equity Buyback for KRW 3,000 million worth of its shares. CI
Cheilbio Co., Ltd. authorizes a Buyback Plan. CI
Cheilbio Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018. CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018. CI
Cheilbio Co., Ltd.'s Equity Buyback announced on March 23, 2018 has expired with 495,436 shares for KRW 1,984.53 million. CI
Tranche Update on Cheilbio Co., Ltd.'s Equity Buyback Plan announced on March 23, 2018. CI
More news

Highs and lows

1 year
1 555.00
Extreme 1555
2 605.00
3 years
1 131.00
Extreme 1131
4 530.00
5 years
1 131.00
Extreme 1131
5 825.00
10 years
1 131.00
Extreme 1131
5 825.00
More quotes

Managers and Directors - Cheilbio Co., Ltd.

Managers TitleAgeSince
Gwang-Gyeong Shim CEO
 Chief Executive Officer 84 -
Dong-Kyun Im AUD
 Comptroller/Controller/Auditor 36 -
Jae-Wan Jang AUD
 Comptroller/Controller/Auditor 81 -
Members of the board TitleAgeSince
Gwang-Gyeong Shim CEO
 Chief Executive Officer 84 -
Yoon-Jung Shim BRD
 Director/Board Member 57 -
Jae-Yoon Kim BRD
 Director/Board Member 49 -
More insiders

Company Profile

Cheilbio Co., Ltd. is a Korea-based company engaged in the manufacturing of veterinary drugs. The Company's offerings consist of antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, diagnostic kits including enzyme-linked immunosorbent assay (ELISA) test kits, virus test kits and deoxyribonucleic acid (DNA) kits, as well as feed additives. The Company’s products are used for cattle, pigs, chickens, pets and other animals. It supplies its products mainly to the domestic market.
Sector
Pharmaceuticals
Calendar
13/05/2024 - Q1 2024 Earnings Release (Projected)
More about the company

Income Statement Evolution

More financial data

Sector Veterinary Drugs

1st Jan change Capi.
CHEILBIO CO., LTD. Stock Cheilbio Co., Ltd.
-.--% 40.84M
ZOETIS INC. Stock Zoetis Inc.
-19.09% 72.97B
ELANCO ANIMAL HEALTH INCORPORATED Stock Elanco Animal Health Incorporated
-8.93% 6.69B
BLUESTAR ADISSEO COMPANY Stock Bluestar Adisseo Company
+21.38% 3.6B
VIMIAN GROUP AB Stock Vimian Group AB
+1.52% 1.44B
JINYU BIO-TECHNOLOGY CO., LTD. Stock Jinyu Bio-technology Co., Ltd.
-16.99% 1.34B
VETOQUINOL SA Stock Vetoquinol SA
-9.57% 1.25B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD. Stock China Animal Husbandry Industry Co., Ltd.
-26.05% 1.24B
WUHAN KEQIAN BIOLOGY CO.,LTD Stock Wuhan Keqian Biology Co.,Ltd
-12.71% 1.15B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD. Stock Tianjin Ringpu Bio-Technology Co.,Ltd.
-4.03% 1.01B
Veterinary Drugs
  1. Stock Market
  2. Equities
  3. A052670 Stock